Pretreatment evaluation of adnexal tumors predicting ovarian cancer

International Journal of Gynecological Cancer

Volumn 9, Issue 6, 1999, Pages 481-486

  Kobal, B ^a   Rakar, S ^a   Ribic Pucelj M ^a   Tomazevic T ^a   Zaletel Kragelj, L ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Adnexal tumors; CA 125; Doppler ultrasonography; Ovarian cancer; Transvaginal sonography

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER RISK; CANCER STAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); OVARY CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; UTERUS TUMOR;

EID: 0033371324     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1999.99057.x     Document Type: Article

References (23)

1. Colombo N, Maggioni A, Bocciolone L, Rota S, Cantu MG, Mangioni C. Multimodality therapy of early stage (FIGO I-II) ovarian cancer: Review of surgical management and postoperative adjuvant treatment. Int J Gynecol Cancer 1995; 6(Suppl): 13-7.
2. Teneriello MG, Park RC. Early detection of ovarian cancer. Can Cancer J Clin 1995; 45: 71-87.
3. Benjamin I, Rubin SC. Management of early stage epithelial ovarian cancer. Obstet Gynecol Clin North Am 1994; 21: 107-19.
4. Maiman M, Seltzer V, Boyce J. Laparoscopic excision of ovarian neoplasms subsequently found to be malignant. Obstet Gynecol 1991; 77: 563-5.
5. Jacobs I, Oram D, Fairbanks J, et al. A risk of malignant index incorporating CA 125, ultrasound and menopausal status for the accurate diagnosis of ovarian cancer. Br J Obstet Gynecol 1990; 97: 922-9.
6. Tingulstad S, Hagen B, Skjeldestat FE, et al. Evaluation of a risk of malignancy index based on serum CA 125, ultrasound findings and menopausal status in the preoperative diagnosis of pelvic masses. Br J Obstet Gynecol 1996; 65: 826-31.
7. Granberg S, Nosrom A, Wikland M. Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol 1990; 65: 573-7.
8. Sassone AM, Timor Tritsch IE, Artner A, Carolyn W, Warren WB. Transvaginal sonographic characterization of ovarian disease: Evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 1991; 78: 706-9.
9. De Priest PD, Shenson D, Fried A, Hunter JE, Andrews SJ, Gallion HH, Pavlik RJ, Kryscio RJ, Van Nagell JR. A morphology index based on sonographic findings in ovarian cancer. Gynecol Oncol 1993; 51: 7-11.
10. Lerner JP, Timor Tritsch IE, Federman A, Abramovich G. Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol 1994; 83: 434-7.
11. Ferrazzi E, Zanetta G, Dordoni D, Berlanda N, Mezzopane R, Lissoni G. Transvaginal ultrasonographic characterization of ovarian masses: Comparison of five scoring systems in a multicenter study. Ultrasound Obstet Gynecol 1997; 10: 192-7.
12. Botsis D, Kassonos D, Kalogirou D, Karakitsos P, Liapis A, Antoniou G. Transvaginal color Doppler and CA 125 as tools in the differential diagnosis of postmenopausal ovarian masses. Maturitas 1997; 26: 203-9.
13. Tailor A, Jurkovic D, Bourne TH, Collins WP, Campbell S. Sonographic prediction of malignancy in adnexal masses using multivariate logistic regression analysis. Ultrasound Obstet Gynecol 1997; 10: 41-7.
14. Hosmer DW, Lemeshow S. The multiple logistic regression model. In: Hosmer DW, Lemeshow S, eds. Applied Logistic Regression. New York: John Wiley & Sons, 1989: 25-37.
15. Bradley GW. Evaluation of tests. In: Disease, Diagnosis and Decisions. Chicester: John Wiley & Sons, 1993: 70-90.
16. Crawford AF, Gore MF, Shepherd JF. Ovarian cancers related to minimal access surgery. Br J Obstet Gynaecol 1995; 102: 726-30.
17. Prompeler HJ, Madjar H, Sauerbrei W, Lattermann U, Pfleiderer A. Diagnostic formula for the differentiation of adnexal tumors by transvaginal sonography. Obstet Gynecol 1997; 89: 428-33.
18. Finkler NJ, Benacerraf B, Lavin PT, Wojciechowski C, Knapp RC. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses. Obstet Gynecol 1988; 72: 659-64.
19. Strigini FAL, Gadducci A, DelBravo B, Ferdeghini M, Genazzani AR. Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women. Gynecol Oncol 1996; 61: 68-72.
20. Troiano RN, Quedent-Case C, Taylor KJW. Correlation of findings on transvaginal sonography with serum CA 125 levels. AJR 1997; 168: 1587-90.
21. Kenemans P, Yedema CA, Bon G, von Mendorff-Pouilly S. CA 125 in gynecological pathology - A review. Eur J Obstet Gynecol Reprod Biol 1993; 49: 115-24.
22. Antonić J, Rakar S. Color and pulsed Doppler US and tumor marker CA 125 in differentiation between benign and malignant ovarian masses. Anticancer Res 1995; 15: 1527-32.
23. Roman LD, Muderspach LJ, Stein SmM, Laifer-Narin L, Groshen S, Morrow CP. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer. Obstet Gynecol 1997; 89: 493-500.